Tristel Dividends - TSTL

Tristel Dividends - TSTL

Buy
Sell
Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Tristel Plc TSTL London Ordinary Share GB00B07RVT99 ORD 1P
  Price Change Price Change % Stock Price Low Price High Price Open Price Close Price Last Trade
-15.00 -3.1% 468.50 457.50 483.50 483.50 483.50 16:14:43
more quote information »
Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Tristel TSTL Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
16/10/2019FinalGBX3.530/06/201830/06/201921/11/201922/11/201920/12/20195.54
25/02/2019InterimGBX2.0430/06/201830/06/201928/03/201929/03/201930/04/20190
17/10/2018FinalGBX2.9830/06/201730/06/201815/11/201816/11/201814/12/20184.58
20/02/2018InterimGBX1.630/06/201730/06/201822/03/201823/03/201812/04/20180
19/10/2017FinalGBX2.6330/06/201630/06/201716/11/201717/11/201715/12/20174.03
23/02/2017InterimGBX1.430/06/201630/06/201723/03/201724/03/201713/04/20170
17/10/2016FinalGBX2.1930/06/201530/06/201617/11/201618/11/201616/12/20166.33
21/07/2016SpecialGBX330/06/201530/06/201628/07/201629/07/201605/08/20160
24/02/2016InterimGBX1.1430/06/201530/06/201617/03/201618/03/201601/04/20160
12/10/2015FinalGBX2.1430/06/201430/06/201519/11/201520/11/201518/12/20155.72
18/06/2015SpecialGBX330/06/201430/06/201525/06/201526/06/201506/08/20150
25/02/2015InterimGBX0.5830/06/201430/06/201526/03/201527/03/201513/04/20150
13/10/2014FinalGBX1.2630/06/201330/06/201420/11/201421/11/201419/12/20141.62
03/03/2014InterimGBX0.3630/06/201330/06/201426/03/201428/03/201428/03/20140
14/10/2013FinalGBX0.3230/06/201230/06/201327/11/201329/11/201316/12/20130.4
04/03/2013InterimGBX0.0830/06/201230/06/201327/03/201302/04/201315/04/20130
29/10/2012FinalGBX0.3530/06/201130/06/201214/11/201216/11/201214/12/20120.62
12/03/2012InterimGBX0.2730/06/201130/06/201221/03/201223/03/201213/04/20120
24/10/2011FinalGBX0.1230/06/201030/06/201116/11/201118/11/201116/12/20110.56
14/03/2011InterimGBX0.4430/06/201030/06/201123/03/201125/03/201115/04/20110
18/10/2010FinalGBX1.4130/06/200930/06/201017/11/201019/11/201017/12/20101.83
08/03/2010InterimGBX0.42530/06/200930/06/201017/03/201019/03/201031/03/20100
12/10/2009FinalGBX1.330/06/200830/06/200919/10/200921/11/200919/12/20091.7
16/03/2009InterimGBX0.40501/07/200831/12/200823/03/200925/03/200922/04/20090
06/10/2008FinalGBX1.1730/06/200730/06/200819/10/200821/11/200819/12/20081.55
03/03/2008InterimGBX0.38501/07/200731/12/200712/03/200814/03/200809/04/20080
11/12/2007FinalGBX130/06/200630/06/200714/11/200716/11/200714/12/20071.35
19/02/2007InterimGBX0.3501/07/200631/12/200628/02/200702/03/200710/04/20070
19/10/2006FinalGBX0.7330/06/200530/06/200601/11/200603/11/200601/12/20061
13/02/2006InterimGBX0.2801/07/200531/12/200508/03/200610/03/200606/04/20060
03/10/2005FinalGBX0.530/06/200430/06/200502/11/200504/11/200502/12/20050.5

Top Dividend Posts

DateSubject
19/3/2020
09:02
makw61: The fall in share price coincided with the announcement that the NHS were stopping routine operations so i guess it reflects concern over reduced demand for instrument decontamination etc. Seems a bit overdone - with high PE stocks most of the value is well into the future, not current year earnings, and the long term prospects have likely increased post Covid 19.
04/3/2020
17:49
metis20: Piedro - "At Tristel the exertion seems minimal, repeating the old formula and letting the momentum carry them forward." What evidence do you have for this?! Did you attend a recent Investor Presentation? The impression I obtained at the late afternoon session was of a decidedly hard working and innovative duo leading the company. Https://www.investegate.co.uk/tristel-plc--tstl-/rns/directors-dealing-grant-of-options/201711020700053213V/ Share holder approval was of course required. Vesting conditions - that was when the share price was £2.75 · One-third will vest upon the achievement of a share price of £3.50; · One-third will vest upon the achievement of a share price of £4.25; · One-third will vest upon the achievement of a share price of £5.00. Between 4 August 2015 and 1 November 2017, the Company's share price has increased from 96 pence to 275 pence, and the Company's market capitalisation has increased from £40 million to £118 million. The Board considers that the 2015 Scheme has successfully met its objectives.
25/2/2019
16:52
salchow: "Profits up, share price down..why?" US approval takes longer and costs more than anticipated. Already an expensive share.
25/2/2019
16:12
trapperjez: Profits up, share price down..why?
28/12/2018
17:31
metis20: From FY (ending June 2018) final results - "The corollary to achieving these targets is that we are likely to be highly cash generative given the operational cash requirements of the business. If the Board considers that there are no earnings enhancing opportunities to invest excess cash, a special dividend will be paid to shareholders. The Board's pursuit of these financial objectives is grounded in the belief that consistent and sustainable increases in earnings and dividends will, over time, result in share price growth." Https://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/TSTL/13831403.html From H1 (ending Dec 2017)report - "During the first half a final dividend of 2.63 pence per share was paid, totalling £1.1m. At the period end cash was £4.9m compared to £3.9m on 31 December 2016. We will pay an interim dividend of 1.6 pence per share on 12 April 2018 to shareholders on the register on 23 March 2018, with an ex-dividend date of 22 March 2018. Our policy is to cover the dividend with earnings by at least two times and pay 40% as an interim and 60% as a final." Https://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/TSTL/13538650.html
24/10/2018
18:41
gopher: Attended the open day in the summer when share price was close to 300p and directors took the opportunity to slot a few At 220p much more reasonably priced for a good quality small cap with opportunity to grow the business. That growth needs to come from abroad as the NHS is a difficult market for all UK suppliers aa there is moral pressure to keep prices low.
18/10/2018
16:43
sportii: Only a good news from the American front can change the momentum of the share price. Sooner the better!
18/10/2018
12:09
piedro: To quote the Walbrock report ... "Look to the cash flow statement, and you see share-based payment rose to £665k from £121k. Management rewarded themselves with large bonuses, despite missing earnings forecast. The cancellation of its special dividends took the yield down to 1.6% from approx. 2.5%. To be fair to management, the company share price rose from 30 pence to £2.59, an increase of 760% in the last five years. Surely, management deserves their bonuses for delivering long-term gains to shareholders." - long term investors will remember the pain back in 2010 when the management took the share price from 60p down to 20p - they had to get in outside help to pick the company up again - now again ... "We are working to appoint new Non-Executive Directors to bring fresh ideas and new experiences to our Board" {Annual Report} - the present chairman was only supposed to be 'Interim' - going by past experience, I am thinking that circumstances are obliging him to let go and there may yet be unwelcome revelations to come - I would not be surprised if it was not this same management that is stifling the young talent within the company AIMO, BWDIK GLA and ride the storm.
17/7/2018
21:43
gopher: I had the impression that the Board members are at a stage in their lives where they want to diversify their wealth having worked hard to make the company successful. Additionally the share price is fairly full at the moment. US looks good but it not going to be instant lift off feeding through to the bottom line quickly, they remain some way from being able to make financial forecasts.
23/4/2018
07:19
zimbtrader: Approval received! Still a long road ahead before we see revenues from US sales but good news nevertheless. Be interesting to see if this announcement has any effect 9n the share price...
ADVFN Advertorial
Your Recent History
LSE
TSTL
Tristel
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200524 22:08:35